Boston Scientific To Participate In The 2014 Leerink Swann Global Healthcare Conference

Boston Scientific To Participate In The 2014 Leerink Swann Global Healthcare Conference

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact pressreleases@worldnow.com.

SOURCE Boston Scientific Corporation

NATICK, Mass., Feb. 3, 2014 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the 2014 Leerink Swann Global Healthcare Conference on Wednesday, February 12, 2014 in New York, NY.

Dan Brennan, executive vice president and chief financial officer, will participate in a 30-minute question and answer session regarding the company beginning at approximately 8:50 a.m. ET.

A live webcast of the question and answer session will be available to interested parties via the Boston Scientific website.  Webcast registration is available on the Investor Relations section of the website at www.bostonscientific.com/investors.  Interested parties are encouraged to register at least 15 minutes prior to the scheduled start time to ensure a timely connection.

This webcast is being hosted by Leerink Swann.  A replay will be archived and available at www.bostonscientific.com/investors beginning approximately one hour following the completion of the question and answer session.

About Boston Scientific
Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world.  As a global medical technology leader for more than 30 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare.  For more information, visit www.bostonscientific.com and connect on Twitter and Facebook.

CONTACTS

Media:  
Denise Kaigler  
508-650-8330 (office)   
Corporate Affairs & Communications    
Boston Scientific Corporation
denise.kaigler@bsci.com       

Investors:         
Susie Lisa, CFA 
508-652-5345 (office)
Investor Relations
Boston Scientific Corporation
investor_relations@bsci.com

©2012 PR Newswire. All Rights Reserved.